This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Janigan, D. T. Articles by Hirsch, D. Search for Related Content PubMed PubMed Citation Articles by Janigan, D. T. Articles by Hirsch, D. Social Bookmarking                         What's this?

Skin Necrosis: An Unusual Complication of Hyperphosphatemia During Total Parenteral Nutrition Therapy

Department of Pathology, Dalhousie University and Victoria General Hospital, Halifax, Nova Scotia

Bernard Perey, MD, FRCS C

Department of Surgery, Dalhousie University and Victoria General Hospital, Halifax, Nova Scotia

Thomas J. Marrie, MD, FRCP C

Department of Medicine, Dalhousie University and Victoria General Hospital, Halifax, Nova Scotia

Patrick M. Chiasson, MD, CM

Department of Surgery, Dalhousie University and Victoria General Hospital, Halifax, Nova Scotia

David Hirsch, MD, FRCP C

Department of Medicine, Dalhousie University and Victoria General Hospital, Halifax, Nova Scotia

Background:. Hyperphosphatemia complicated by calcification of subcutaneous arteries and skin infarcts are very rarely reported in the absence of chronic renal failure (CRF). We describe identical lesions in an obese woman with sepsis. Hyperphosphatemia resulted from an unintended excess of phosphate in her total parenteral nutrition (TPN) formulations. She did not have CRF or hyperparathyroidism. Methods: The patient's records during 37 weeks of hospitalization 12 years ago and, subsequently, her outpatient records were reviewed. Results: During a 7-week period, the total elemental phosphorus infused daily, as divalent phosphate, ranged from 1.8 to 4.2 g, median 3.1, over triple the normal daily requirement. This excess was unintended. This occurred before the current practice of pharmacist-monitoring of TPN formulations, and possibly resulted from misinterpretation of a revised formulation sheet, newly introduced to the nursing units at the start of that period. Serum phosphorus increased to 3.02 mmol/L (normal 0.76 to 1.46 mmol/L). She developed calcification of subcutaneous arteries, which was complicated by widespread infarcts of the anatomically related skin and subcutis, apparently the result of hypoperfusion of these vessels during an episode of septic shock. The infarcts were heralded by unusual, blotchy skin discolorations. Conclusions: This report, illustrating a startling cutaneous complication associated with apparent misinterpretation of TPN formulations, demonstrates a pathogenetic relationship between hyperphosphatemia, calcification of subcutaneous arteries, and necrosis of the skin and subcutis in the absence of CRF and hyperparathyroidism and introduces a new differential diagnosis for unusual skin lesions appearing during TPN therapy. (Journal of Parenteral and Enteral Nutrition 21:050-052, 1997)

Journal of Parenteral and Enteral Nutrition, Vol. 21, No. 1, 50-52 (1997)
DOI: 10.1177/014860719702100150


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. T. Janigan and D. J. Hirsch Does obesity play a role in the pathogenesis of calcific uraemic arteriolopathy? Nephrol. Dial. Transplant., April 1, 2006; 21(4): 865 - 868. [Full Text] [PDF]